Cytek Biosciences, Inc., a leading innovator in the field of flow cytometry, is headquartered in the United States, with significant operations across North America, Europe, and Asia. Founded in 2014, the company has rapidly established itself as a key player in the life sciences industry, focusing on advanced cell analysis technologies. Cytek is renowned for its unique spectral flow cytometry systems, which offer unparalleled sensitivity and resolution, enabling researchers to gain deeper insights into cellular functions. Their flagship products, including the Aurora and Northern Lights systems, are distinguished by their ability to analyse complex samples with high-dimensional data. With a commitment to advancing scientific research, Cytek Biosciences has achieved notable milestones, including rapid growth in market share and recognition for its innovative solutions, solidifying its position as a trusted partner in the global scientific community.
How does Cytek Biosciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Cytek Biosciences, Inc.'s score of 25 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cytek Biosciences, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. As a result, there are no reported figures for their Scope 1, 2, or 3 emissions. The company has not outlined any formal climate commitments or initiatives aimed at reducing carbon emissions. In the context of the industry, many companies are increasingly focusing on sustainability and setting science-based targets to mitigate their environmental impact. However, without specific data or commitments from Cytek Biosciences, it is unclear how they are addressing climate change and carbon emissions.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cytek Biosciences, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.